# Effect of Lutein in S-26 Gold On Growth And Safety

> **NCT00913406** · NA · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 232 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Lutein fortification
- **OTHER:** Standard formula

## Key facts

- **NCT ID:** NCT00913406
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2009-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00913406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00913406, "Effect of Lutein in S-26 Gold On Growth And Safety". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00913406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*